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INTRODUCTION:  
Anemia is a medical condition in which the 
carrying capacity of red blood cells for oxygen 
becomes inadequate to fulfill the physiological 
requirements of the body. It may cause very severe 
health problems during pregnancy and may have 
severe side effects on both maternal and fetal 
outcomes. The World Health Organization defines 
anemia as the concentration of hemoglobin <11g/dl 
ABSTRACT:  
OBJECTIVES:  
The objective of this study was  to determine frequency of non-compliance to oral iron therapy in pregnancy and 
common factors leading to it.  
METHODOLOGY:  
It was a cross-sectional study  done in the Department of Obstetrics and  Gynecology of  Lady Willington Hospital 
Lahore, Pakistan. The duration of this study was  six  months  i.e.,  3
rd
 October  2019  to 2
nd
 March  2020.  All antenatal 
patients between ages  of 18 to 45 years presented in the obstetrics  outdoors  or admitted in the ward were included 
in this study. A  total of 245 patients were included in this study by consecutive non-probability  sampling. Patients  
with gynecological problems, patients dependent on others  for their medication cost, patients with psychiatric 
illness or physical disability were excluded.  Post stratification Chi-square test was applied keeping P-value ≤0.05 as 
significant  
RESULTS:  
Among 245 patients, mean age was 27±2.16 years. Iron supplement used by 245 patients was analyzed as 159 
(65%) patients had used the iron supplement while 86  (35%) patients didn’t use  iron supplements  (P-value 0.001).  
Iron supplement used by 245 patients was analyzed and only 93 (38%) patients had used the iron supplement while 
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or hematocrit <37% during pregnancy1. All over 
the world, 42% of females of reproductive age 
have anemia and about 50% of these females have 
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anemia because of deficiency of iron content in 
blood3. In Pakistan, it has been estimated that 
anemia in pregnancy is observed in 51% pregnant 
females. In Pakistan oral iron supplements are 
distributed by Maternal and Child Health (MCH) 
services through primary health care facilities 
including lady health workers. One of the main 
reasons for iron supplements programs failure is 
non-compliance2. In Pakistan, it has been estimated 
that anemia in pregnancy is observed in 51% 
pregnant females. Maternal anemia is significantly 
associated with high maternal mortality rate and 
poor obstetric outcomes9. A trial in China showed 
47% reduction in neonatal mortality when pregnant 
women were given antenatal oral iron folic acid 
supplements4. The World Health Organization 
recommends daily prophylactic doses of oral iron 
supplements especially in prevalent areas23. The 
World Health Organization defines non-
compliance as the degree to which a person‟s 
behavior to take the medicines, following the diet 
or accomplishing the changes in lifestyle, matches 
with the agreed recommendation from the health 
care provider. Several factors play significant roles 
in whether the person fulfills their treatment and 
pregnancy offers the exclusive encounter as non-
compliance can pose many serious health issues, 
not only to the mother but also the fetus15. The 
overall non-compliance rate in pregnancy is 
predicted as 43% in Pakistan. In comparison to 
other countries, the rate of non-compliance to iron 
folic acid supplements is found lowest in Pakistan 
(40%)11. In one study conducted in Nigeria 
compliance for oral iron was found to be 65.9%22. 
In a study in Peru compliance was found to be 
79%. In south India compliance for iron folic acid 
was reported to be 64.7%. Common factors leading 
to non-compliance to oral iron therapy include 
illiteracy (70.3%), living in rural areas (64.3%), 
maternal age of 45 years and above (81.4%), 
lowest socio-economic status (74.7%) and poor 
health education (73.2%)8. As most of the studies 
are from developed countries and limited data 
exists regarding factors leading to non-compliance 
to oral iron therapy in Pakistan, it is obvious that 
there is a lot of social difference including literacy 
rate, economic, cultural and environmental 
differences between developed countries and our 
region. Hence, we expect that the factors affecting 
compliance to oral iron therapy may be different in 
our community than the developed countries. 
Therefore, we designed this study to identify the 
factors responsible for non-compliance to oral iron 
therapy in antenatal patients in our community. 
only 93 (
METHODOLOGY: 
It was an observational cross-sectional study 
conducted in the Obstetrics and Gynecology 
Department of Lady Willington Hospital Lahore, 
which is the teaching hospital of King Edward 
Medical University Lahore Pakistan. The duration 
of the study was six months i.e., 3rd October 2019 
to 2nd March 2020. A total of 245 patients were 
included in this study using 64.3% proportion of 
common factors leading to non-compliance to oral 
iron therapy in pregnancy, 95% confidence level, 
6% margin of error with the help of WHO 
software7. Inclusion criteria included all 
consecutive pregnant female patients between the 
ages of 18 to 45 years presented to obstetrics 
outdoors or already admitted in gynae ward and 
labor room. Exclusion criteria include patients with 
other gynecological problems, patients dependent 
on others for their medication cost, patients with 
psychiatric illness or physical disability and those 
patients who were prescribed injectable iron 
supplements by a qualified medical specialist. 
Informed verbal consent was taken after explaining 
to the patients the purpose and benefits of the study 
and with the permission that the study was only for 
data review and publication. All the information 
taken from the patient was recorded on a pre-
designed proforma on the spot. Data was analyzed 
by SPSS version 26. Mean±SD was calculated for 
numerical variables like age, gravid, para and 
duration since live birth. Frequency in percentage 
was calculated for categorical variables like iron 
supplements used, period of gestation and common 
factors (affordability, health literacy, resident). 
Common factors were stratified among age, period 
of gestation and iron supplements used. Post 
stratification Chi-square test was applied keeping 
P-value ≤0.05 as significant. All the results were 
presented in the form of tables. 
RESULTS: 
Among 245 patients the mean age was 27±2.16 
years. The age groups of patients, literacy level, 
gravid status, parity status and interpregnancy 
interval are described in Table 1. Duration since 
live birth 245 patients was analyzed as 172 (70%) 
patients have their last delivery ≤3 years while 73 
(30%) patients have their last delivery >3 years. 
Mean duration was 3±1.77 years (Table 1). Iron 
supplement used by 245 patients was analyzed and 
38%) patients had used the iron 
supplement while 152 (62%) patients didn’t use 
iron supplements. Non-affordability, knowledge of 
tablets prescribed, period of gestation and 
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compliance to oral iron therapy during pregnancy is mentioned in Table 2.
 
Table 1: Characteristics of Patients
 
Age Groups                                                                                     Frequency                                                                             Percentage  
18-25 Years                                                                                               81                                                                                     33%
26-35 Years                                                                                            103                                                                                  42%
36-45 Years                                                                                                61                                                                                  25%
Educated                                                                                                  54                                                                                 22%
Uneducated                                                                                              191                                                                                  78%
Primary Gravida                                                                                    78                                                                                            32%
Multigravida                                                                                          167                                                                                      68%
Primipara                                                                                                 93                                                                                         38%
Multipara                                                                                               152                                                                                     62%
Interpregnancy Interval  
≤3 Years
                                                                                                   
172                 
                                                                         
70%
>3 Years
                                                                                                  
73                  
                                                                          
30%
 
Primary Gravida=pregnant for 1st time (fetus alive 
or dead) or delivered single alive baby in the past, 
Multigravida=pregnant for more than 1 time in the 
past (fetus alive or dead). Primary Parous=female 
who delivered 1 alive baby, Multiparous=female 
who delivered more than 1 alive babies. 
In this study the compliance to use antenatal iron 
and folic acid supplements was low with only 38% 
(n=93) of women reported consumption of antenatal 
iron and folic acid supplements during their 
pregnancy. In our study only 22% (n=54) of females 
were literate. In a study done in Vietnam it was 
estimated that a total of 73% of literate women 
reported high compliance when compared with 
women who were not literate who showed a 50% of 
compliance18. Almost similar results are stated in a 
study done in Toronto which shows compliance is 
better in educated pregnant females as compared to 
uneducated pregnant females12. This shows that 
educated pregnant females responded well to iron 
and folic acid supplements as compared to 
uneducated ones. In our study, a substantial majority 
of women 46% initiated the supplements in their 
third trimester of pregnancy, with an average 
initiation in the fifth month of pregnancy. A study 
done by Larson et al showed almost similar results 
that pregnant females get more attention from 
 
doctors in their third trimester14. Many factors are 
responsible for this attitude. As the size of the uterus 
grows more in the third trimester and the growth 
needs of the baby increase rapidly, it takes more 
nutrition from the mother and hence weakness, 
fatigue is more prominent in the third trimester16. 
Only 15% of patients in our study had the 
knowledge of prescribed tablets while 85% of 
patients had no knowledge of prescribed tablets. 
This is because of the low education level of 
females in rural areas of Pakistan. In a study done in 
India, the socioeconomic status of Asian women 
living in rural areas is very poor and the majority of 
them are uneducated. The only health care service 
they have is a small dispensary that is run by a non-
doctor paramedic. In a study done by Thomas et Al, 
the miscarriage rate is about 14% in rural areas of 
south Punjab of Pakistan where major health 
services are not available20. According to a Pakistan 
Table 2: Factors Affecting Non-Compliance  
 Frequency  Percentage  P-Value  
Non-Affordability  
Yes  159  65%  0.015  
No  86  35%  
Knowledge About Oral Iron 
Supplements  
Yes  37  15%  0.001  
No  208  85%  
Period of Gestation  
1st  Trimester  56  23%  
0.08  



























demographic and health survey done in 2012-2013, 
only 45% of pregnant women consumed antenatal 
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iron folic acid supplements during their pregnancy, 
which is further lowered to 39% in rural areas. This 
level is highest in Islamabad and lowest in 
Balochistan province. In comparison to other 
countries the usage of iron folic acid supplements is 
lowest in Pakistan that is 40% while non-
compliance to take iron and folic acid supplements 
is reported to be 58%. Common factors leading to 
non-compliance to oral iron therapy are illiteracy 
(70.3%), living in rural areas (64.3%), maternal age 
45 and above (81.4%), belonging to lowest socio-
economic status (74.7%), poor health literacy 
(73.2%)13. The results of our study showed that 
illiterate females had higher chances of non-
compliance to iron and folic acid supplements 
during the pregnancy. The results are consistent 
with previous surveys conducted in South Asia or in 
other continents, which testified a significant 
association between low education statuses. This is 
because educated females have more access to the 
information regarding health during pregnancy, 
which improves their apprehension about their 
pregnancy and health of their neonate and also the 
utilization of antenatal care services, as compared to 
the illiterate females19. In our study, females aged 
45 years or more are also recognized as an 
independent risk factor for non-compliance to 
antenatal iron and folic acid supplementation. 
Surveys conducted in Pakistan, India, Nepal and 
Bangladesh have also found similar results with 
higher rates of older aged females not taking 
antenatal iron and folic acid supplementation as 
compared to younger females6. Many surveys 
observed young age females as the risk factor for 
non-compliance of antenatal iron and folic acid 
supplementation. In developing countries, females 
of old age have more knowledge of pregnancy and 
child-birth and usually they do not feel the iron and 
folic acid supplements needed in pregnancy as they 
did not take these in previous pregnancies17. In 
contrast to that, one study found that the high 
sociodemographic status could be a risk factor for 
non-compliance of iron and folic acid 
supplementation in pregnancy. In developing 
countries, females belonging to poor socio 
demographic status normally don‟t use antenatal 
care services because of their restricted resources5. 
In Pakistan, the rate of utilization of antenatal care 
from health care professionals is 73% in pregnant 
females, which could lead to less access to the 
antenatal iron and folic acid supplements10. Another 
study showed that in developing countries, limited 
access of pregnant females to antenatal care is the 
major cause for non-compliance to the iron and folic 
acid supplements and because of this reason, World 
 
Health Organization focused on antenatal care 
which is composed of four visits in pregnancy 
instead of previous schedules of visits in every 
month and to dispense of iron and folic supplements 
to all pregnant females at each visit21.  
LIMITATIONS: 
There are certain limitations to the study as well. 
The sample size of the study is very small and 
studies with large sample sizes are needed to extract 
more information regarding the real nature of the 
problem in Pakistan. Also, it is a single center study. 
More studies in high volume centers are needed. 
CONCLUSION: 
The compliance of antenatal iron and folic acid 
supplements by pregnant females is very low in the 
surveyed districts of Pakistan and this is due to the 
lack of parental education, old aged women 
belonging to poor socioeconomic status and lack of 
antenatal care services. All these factors were 
significantly associated with non-use of these 
supplements. The results of this study highlighted 
the serious need to improve the efforts, which will 
target the pregnant ladies by successful coverage of 
antenatal care to increase the use of iron and folic 
acid supplements during pregnancy in Pakistan. 
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